Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Johnson & Johnson buy Traumtanz

Johnson & Johnson
Start price
€119.51
17.07.19 / 50%
Target price
€135.30
19.07.19
Performance (%)
-1.65%
End price
€117.54
19.07.19
Summary
This prediction ended on 19.07.19 with a price of €117.54. With a performance of -1.65%, the BUY prediction by Traumtanz finished with a loss. Traumtanz has a follow-up prediction for Johnson & Johnson where he still thinks Johnson & Johnson is a Buy. Traumtanz has 50% into this prediction

Johnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.

Performance without dividends (%)
Name 1w 1m 1y 3y
Johnson & Johnson -1.269% -1.269% -6.730% 1.093%
iShares Core DAX® -1.670% -1.001% 10.864% 12.563%
iShares Nasdaq 100 -4.184% -1.145% 37.458% 41.078%
iShares Nikkei 225® -4.967% -5.783% 18.828% 0.655%
iShares S&P 500 -2.834% -0.572% 25.875% 39.960%

According to Traumtanz what are the pros and cons of Johnson & Johnson for the foreseeable future?

Pros
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Valuable balance sheet
ROE higher than 10% per year
Capable Management
Good culture
Innovative
Some uniques
Growths faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Medium risks for its business
Top 10 in its market
Small cyclical dependencies
Known brand
Future proof or reliable business model
Normal challenges to pay loans and raise capital
Differentiated customer and product portfolio
Cons

Comments by Traumtanz for this prediction

In the thread Johnson & Johnson diskutieren
Prediction Buy
Perf. (%) -1.65%
Target price 135.300
Change
Ends at 19.07.19

Johnson & Johnson

https://www.finanzen.at/nachrichten/aktien/johnson-&-johnson-aktie-gibt-nach-j&j-kann-gewinn-kraeftig-steigern-und-hebt-umsatzausblick-an-1028355828


Johnson & Johnson ist ein weltweit tätiger amerikanischer Pharmazie- und Konsumgüterhersteller mit Hauptsitz in New Brunswick im US-Bundesstaat New Jersey. 2016 eines der größten Healthcareunternehmen der Welt. Die Pharmasparte firmiert in erster Linie unter Janssen und machte 2015 31,4 Milliarden US-Dollar Umsatz. Es gibt auch OTC- resp. Medizinprodukte-Sparten.
(WIKI)

Wiedereingestellt nach SL - Ende. Ich war in J&J selbst auch schon investiert, habe sie aber aktuell nicht mehr.


https://www.onvista.de/news/johnson-johnson-hebt-ausblick-erneut-an-67483123


u.U. kein schlechter EInstiegspunkt.

Traumtanz 
0
Report Share
17.07.19
Prediction Buy
Perf. (%) -1.65%
Target price 135.300
Change
Ends at 19.07.19

(Stop Loss Kurs erreicht)

Traumtanz 
0
Report Share
19.07.19

Current prediction by Traumtanz for Johnson & Johnson

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€157.90
16.08.23
€160.00
16.08.24
-10.61%
19:35

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Traumtanz 
16.08.23 50%

Stopped prediction by Traumtanz for Johnson & Johnson

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€152.60
24.07.23
€155.00
24.07.24
3.47%
16.08.23

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Traumtanz 
24.07.23 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€145.40
11.07.23
€155.00
11.07.24
4.95%
24.07.23

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Traumtanz 
11.07.23 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€171.94
26.09.22
€150.00
26.09.23
-15.44%
11.07.23

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Traumtanz 
26.09.22 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€123.90
21.11.20
€140.00
2.62%
10.12.20

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Traumtanz 
21.11.20 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€140.64
29.04.20
€155.00
30.04.20
-2.23%
30.04.20

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Traumtanz 
29.04.20 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€113.30
26.03.20
€145.00
20.04.20
23.88%
20.04.20

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Traumtanz 
26.03.20 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€121.12
10.03.20
€130.00
20.03.20
-4.23%
20.03.20

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Traumtanz 
10.03.20 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€119.52
17.07.19
€135.30
17.07.19
0.00%
17.07.19

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Traumtanz 
05.08.19 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€131.89
11.12.18
€135.30
17.12.18
-11.67%
17.12.18

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Traumtanz 
05.08.19 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€118.87
25.07.17
€135.30
23.03.18
-2.81%
23.03.18

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Traumtanz 
05.08.19 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€102.29
28.01.17
€135.30
24.07.17
19.63%
24.07.17

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Traumtanz 
05.08.19 50%